ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	145	167	208	265	268	73
Market Cap Growth	-11.68%	-19.62%	-21.59%	-1.05%	267.26%	337.08%
Enterprise Value	124	158	182	223	272	70
PE Ratio	-	-7.57	-12.65	-18.41	-39.52	-13.17
PS Ratio	5.56	6.98	10.12	16.27	20.90	6.51
PB Ratio	4.20	7.90	5.64	5.44	112.77	15.92
P/FCF Ratio	-14.34	-11.32	-12.01	-20.62	-32.34	-24.25
P/OCF Ratio	-15.44	-12.18	-12.86	-20.89	-34.34	-25.61
EV/Sales Ratio	4.74	6.59	8.88	13.71	21.21	6.22
EV/EBITDA Ratio	-8.42	-7.52	-11.71	-17.53	-56.82	-16.10
EV/EBIT Ratio	-7.75	-7.03	-11.16	-16.63	-50.97	-15.21
EV/FCF Ratio	-12.66	-10.69	-10.54	-17.37	-32.82	-23.17
Debt / Equity Ratio	0.40	0.66	0.32	0.25	10.15	0.54
Debt / EBITDA Ratio	-0.72	-0.66	-0.77	-0.96	-5.04	-0.57
Debt / FCF Ratio	-1.09	-0.94	-0.69	-0.95	-2.91	-0.82
Quick Ratio	2.50	3.55	5.92	11.88	6.87	1.77
Current Ratio	3.14	4.87	7.54	13.02	7.96	2.71
Asset Turnover	0.56	0.52	0.35	0.23	0.52	0.97
Interest Coverage	-	-	-201.90	-13.81	-3.70	-4.80
Return on Equity (ROE)	-76.90%	-83.90%	-39.80%	-31.20%	-409.40%	-123.50%
Return on Assets (ROA)	-43.90%	-47.90%	-27.90%	-20.50%	-27.70%	-48.00%
Return on Capital (ROIC)	-43.24%	-63.92%	-33.42%	-21.90%	-23.47%	-65.16%
Earnings Yield	-14.19%	-13.21%	-7.90%	-5.43%	-2.53%	-7.59%
FCF Yield	-8.80%	-8.84%	-8.32%	-4.85%	-3.09%	-4.12%
Buyback Yield / Dilution	-3.53%	-1.75%	-16.63%	-30.82%	-20.48%	-20.38%
Total Shareholder Return	-3.53%	-1.75%	-16.63%	-30.82%	-20.48%	-20.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).